INSIGHTS ON FACILITY DESIGN
-
![Pharmaceutical Production GettyImages-1212679721]( "Downstream Processing In The Age Of Precision Medicine")
Downstream Processing In The Age Of Precision MedicineExplore alternative processes and solutions being suggested to combat the bottleneck created by downstream processing that is seriously impacting the overall production of treatments and vaccines.
-
![KUBio_CY27565-300922-VI_Thumbnail]( "Addressing Rapid Biomanufacturing Capacity Needs")
Addressing Rapid Biomanufacturing Capacity NeedsAdapt to evolving biomanufacturing demands and rapid capacity needs with a KUBio™ box environment, KUBio™ modular facility and integrated FlexFactory™ configurable manufacturing train.
-
![Cytiva]( "Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility Needs")
Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility NeedsBionova Scientific shares how a CDMO can offer biopharma companies the flexible capacity they need to meet the growing needs for medicines today and in the future.
-
![Pall screenshot]( "Systems To Facilitate Speed To Market And Manufacture Of New Therapies")
Systems To Facilitate Speed To Market And Manufacture Of New TherapiesHear how the bioprocessing industry has evolved over the last few years and learn more about our investment in designing modular systems to help speed up the development of life-saving therapies.
-
The Power Of Modular Design9/30/2022
Learn how modular design has the potential to provide a solution for the increasing pressure and demand for biologics.
-
Get Your Aseptic Facility Ready For EU GMP Annex 17/21/2022
We review the points to consider for contamination control strategy (CCS), the setup of a microbiological environmental monitoring program, and how to optimize the design of hardware and consumables for specific environments.
-
The Critical Role Of CDMOs In Driving Biomanufacturing Resilience7/18/2022
CDMOs play a critical role in advancing the growing pipeline of novel products. Innovators can utilize the advantages of these strategic collaborations for assurance of their projects.
-
Demonstrating ROI For Increased Digital Plant Maturity4/28/2022
Cytiva has partnered with Biopharm Services, to model the costs and associated benefits of increasing digital maturity for monoclonal antibody processes in a biopharma plant utilizing single-use technology.
-
Accelerator℠ Vision Platform3/11/2022
The Pall Accelerator Vision Platform gives you the ability to create virtual replicas of process equipment displayed in your manufacturing facility.
FACILITY DESIGN SOLUTIONS
-
![Pharma bioprocess quality GettyImages-1138461306]( "Metrology Teams Collaborating With Waters")
Explore how we can collaborate and customize our service types to help reduce your workload, decrease instrument downtime, and maintain quality standards to meet regulatory requirements.
-
![mammalian]( "Mammalian Cell Culture Manufacturing")
Explore the new state-of-the-art manufacturing facility ready for clinical and commercial mammalian cGMP manufacturing.
-
![GettyImages-155373764-cryopreservation-cold-chain]( "Transport Simulation Laboratory")
The Transport Simulation Laboratory (TSL) consists of a large environmental chamber equipped with a control system, calibrated sensors, and a validated data collection system with mechanical and hydraulic equipment that can simulate a customized distribution environment profile.
-
![genderless-aseptiquik-l-series-connectors]( "Genderless AseptiQuik® L Series Connectors")
Genderless AseptiQuik® Large Format 3/4", 1" and 1½" sanitary Connectors enable quick and easy sterile connections, even in non-sterile environments. The easy-to-use genderless design simplifies system integration and minimizes the risk of operator error. The connector's robust construction provides enhanced user confidence and reliable performance without the need for clamps, fixtures or tube welders. Biopharmaceutical manufacturers benefit from a full range of interchangeable 3/4" to 1½" flow solutions for production environments with the quality and market availability they expect from the leader in single-use connection technology.
-
In biomanufacturing the only certainty is risk and the only constant is change. Technology is pushing new frontiers, new markets are opening up across the globe, and new competition is creating new levels of urgency—all under the ever more watchful eye of regulators.
